Keeping you updated on the latest Medicare and Part D news

FDA Approves Abuse-Deterrent Opioid

Leave a comment

The FDA recently approved Targiniq ER, a painkiller that contains both oxycodone, a powerful opioid, and naloxone, which is used to prevent fatal opioid overdose. When swallowed intact, the naloxone component of Targiniq ER stays dormant. However, when the pill is crushed, the naloxone component is activated and prevents the oxycodone from binding to brain receptors to provide pain relief. Though people could still become addicted or overdose when using the drug as intended, Targiniq ER limits the common abuse delivery routes such as injecting or snorting crushed pills.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s